On April 19, 2024, Biogen released an update to the SMA community sharing recent data presentations from Spring conferences and latest updates from their SPINRAZA® (nusinersen) clinical development program.
Read the full community statement here.
"We aspire to address the unmet needs of the SMA community and are grateful to individuals throughout the community for their willingness to share their family’s lived experiences to enrich our collective and clinical understanding of SMA."
